About Windhoek Healthcare

News Headlines

Windhoek Healthcare LLC is a healthcare investment firm started by senior executives of the pharmaceutical industry. It is seeking to maximize investor returns while pursuing opportunities that improve human healthcare. Our current focus is in Specialty Pharmaceuticals and Biotechnology.

In December of 2011, Windhoek Healthcare launched its second company, Laurel Pharmaceuticals, Inc. to focus on novel delivery of existing medicines.

2016

North Creek Pharmaceuticals launches dapsone tablets in the United States

Laurel Pharmaceutical's University partner successfully completes Phase 2 PoC trial for novel otitis media treatment

North Creek Pharmaceuticals receives FDA approval for dapsone tablets

North Creek Pharmaceuticals receives FDA approval for tranexamic acid for injection

2015

Laurel Pharmaceutical's University partner commences Phase 2 PoC trial for novel Otitis Media treatment

North Creek Pharmaceuticals signs development and distribution agreement with Virtus Pharmaceuticals

North Creek Pharmaceuticals acquires the rights to a portfolio of products from a leading South Korean manufacturer

2014

Laurel Pharmaceuticals files Patent application with USPTO on novel Otitis Media Treatment

2013

Laurel Pharmaceuticals files two PCTs patent application for novel drug formulation

2012

North Creek Pharmaceuticals signs a strategic commercialization and drug development partnership

2011

Laurel Pharmaceuticals enters into strategic University agreement to develop novel products

Laurel Pharmaceuticals Commences operations

North Creek Pharmaceuticals submits its first ANDA

2010

North Creek Pharmaceuticals commences operations

Windhoek Healthcare initiates first fund to launch start-up pharmaceutical business

© Windhoek Healthcare LLC. 2011. All Rights Reserved.